GS
GSK PLC
GSKOwnership as of Q2 2026
Funds owning
6
Combined value
3.3B
Avg portfolio %
1.2%
Buys / Sells this quarter
+1 buys−5 sells
Q2-2026
| Investor | Weight | Q/Q change | Value |
|---|---|---|---|
HC Hillman Capital Management, Inc.as of Q1-2026 | Trial 3.73% | ↘Reduced 14.78% | 97.4K shares · $55.19 $5.4M |
D& Dodge & Coxas of Q1-2026 | Trial 1.78% | ↘Reduced 14.38% | 58.7M shares · $55.19 $3.2B |
KB Kahn Brothers Groupas of Q1-2026 | Trial 1.58% | ↘Reduced 9.91% | 161.0K shares · $55.19 $8.9M |
TB Tweedy Browne Coas of Q1-2026 | Trial 0.36% | ↘Reduced 0.56% | 81.8K shares · $55.19 $4.5M |
CC Causeway Capital Managementas of Q1-2026 | Trial 0.01% | ↘Reduced 67.22% | 11.1K shares · $55.19 $613,177 |
PI Pzena Investment Managementas of Q1-2026 | Trial 0.00% | ↗Added 40.01% | 18.8K shares · $55.19 $1.0M |
| 6 funds | $3.3B |